Oncology Drugs
PARP Inhibitors: How These Targeted Drugs Exploit Cancer's DNA Repair Weaknesses
PARP inhibitors like Lynparza exploit DNA repair weaknesses in BRCA-mutated cancers. Discover how they work, who...
Read More